| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.08B | +3.9% |
| Cost of Revenue | $2.45B | +6.6% |
| R&D Expense | $539.0M | +6.1% |
| SG&A Expense | $2.01B | +0.4% |
| Interest Expense | $221.0M | -1.3% |
| Pre-tax Income | $2.66B | +6.8% |
| Income Tax | $545.0M | +20.0% |
| Net Income | $2.11B | +3.8% |
| EPS (Basic) | $4.51 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.22B | +7.2% |
| Inventory | $2.35B | +21.9% |
| Current Assets | $7.51B | +8.3% |
| Total Assets | $14.93B | +7.4% |
| Current Liabilities | $3.17B | +76.2% |
| Long-term Debt | $6.55B | -0.6% |
| Total Liabilities | $10.52B | +12.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.91B | -13.6% |
| Capital Expenditures | $586.0M | +22.9% |
| Investing Cash Flow | -$883.0M | -92.8% |
| Financing Cash Flow | -$904.0M | +51.5% |
| Free Cash Flow | $1.33B | -23.6% |
| +5.1% |
| EPS (Diluted) | $4.49 | +5.2% |
| Stockholders' Equity |
| $4.41B |
| -3.0% |